Ims Unison University: SUBMITTED TO: - MS. Divya Rathor Faculty of Law Iuu
Ims Unison University: SUBMITTED TO: - MS. Divya Rathor Faculty of Law Iuu
UNIVERSITY
SUBMITTED BY:-
RASHMI GARG
IUU15BBL003
BBALLB- SEM5
TITLE
Trade Related Aspects of Intellectual Property Rights: A Viable Tool for the
Enforcement of Benefit Sharing?
AREA
INTELLECTUAL PROPERTY
RIGHTS
ABSTRACT
TRIPS Principles
The basic principles are-
It mandates countries to provide patents for products and processes in all fields of
technology, subject to the tests of novelty, inventiveness and industrial use.
It mandates patenting of ‘micro-organisms’ and non-biological and microbiological
processes.
It also gives states the option for protecting new plant varieties through patents or
through any other effective sui generis system.
TRADITIONAL KNOWLEDGE
The 1992 Convention on Biodiversity promotes the need to ‘respect, preserve and
maintain’ traditional knowledge for ‘the conservation and sustainable use of biological
diversity’ and encourages the ‘equitable sharing of benefits arising from the utilization
of such knowledge. Traditional knowledge can refer to knowledge that is in some way
nationally held (such as ayurvedic medicine and Chinese herbal medicine), Traditional
knowledge tends to be passed down over generations and held collectively. It provides
legitimacy, as a first step towards benefit sharing of the knowledge and the resources
that these communities posses.
Every State shall have sovereign rights over the biological and genetic resources within its
territory, and can establish laws to regulate access to those resources
Access to such resources should be on ‘mutually agreed terms’ and should incorporate the
principles of ‘prior informed consent’ of the resource provider.
Every Contracting Party of the CBD shall make efforts to develop and carry out scientific
research based on genetic resources provided by other Contracting Parties with the full
participation of, and to the extent possible, within the countries supplying the genetic
material.
Contracting Parties should adopt legislative, administrative and policy measures that could
ensure effective participation in biotechnological research activities by those Contracting
Parties, especially developing countries, which provide the genetic resources for such
research, and where feasible in such Contracting Parties.
Each Contracting Party shall take legislative, administrative or policy measures, as
appropriate, with the aim that the private sector facilitates access to, joint development and
transfer of technology for the benefit of both governmental institutions and the private
sector of developing countries.
States should:
i) respect, preserve and maintain knowledge, innovations and practices of indigenous and
local communities embodying traditional lifestyles relevant for the conservation and
sustainable use of biological diversity,
ii) promote their wider application with the approval and involvement of the holders of
such knowledge, innovation and practices, and
iii) encourage the equitable sharing of benefits arising from the utilization of such
knowledge, innovations and practices.
The Patent Act 1970 as Amended in 2002 and 2005
The applicant must disclose the source of geographical origin of any biological
material developed (Section 10(d))
If the applicant does not disclose or wrongly mentions the source geographical
origin of biological material used for invention, then it becomes the ground for
refusal of the patent (Section 25)
Cases
Turmeric case
Turmeric The crux of the issue in this case was the patent issued by USPTO to the University of
Mississippi Medical Centre in 1995 for its use in wound healing. In fact, the patent holders were
two non-resident Indians –Suman Das and Harihar Cohli. The CSIR raised objections and
submitted 32 references from ancient Indian scriptures. The issue herein was twofold:
The TRIPS Agreement allows the granting of patents for inventions that use genetic
material without requiring that the provisions of the CBD in relation to prior informed
consent and benefit sharing are respected. Two approaches, not necessarily mutually
exclusive, have been taken by Members in addressing these and other concerns
regarding the mutual supportiveness of the two Agreements.
Conclusion
The Agreement on TRIPS and the Convention on Biological Diversity (CBD) in a
mutually supportive manner has become imperative at the present juncture from the
point of view of protecting the interests of developing countries. Initiatives for realising
this objective have been taken in the WTO where a number of developing countries
have coordinated their efforts in this regard. Issues that will have to be resolved in the
discussions will be the form and content of the actual clarification/amendment to the
TRIPS Agreement the nature of obligation that is placed on the patent applicant and
benefit sharing that can be regarded as acceptable in patent applications. In other
words, developing countries should look for a solution to the vexed problem that the
present paper dealt with, which can be effectively enforced.